Interferon Alpha 2B Treatment and Hair Loss in Malignant Melanoma Patients

    May 1992 in “ Reactions Weekly ”
    NULL AUTHOR_ID
    Image of study
    TLDR Some patients lost hair after taking interferon alpha 2B, but it improved for some while still on the treatment and for others after stopping it.
    Five patients, aged between 41 and 66 years, experienced hair loss diagnosed as telogen effluvium after undergoing treatment with interferon alpha 2B for malignant melanoma. The treatment duration ranged from 10 to 28 weeks, with dosages between 1 and 10 million units administered three times per week. Two of the patients showed improvement in their telogen count even while continuing the treatment, whereas the remaining three patients did not see an improvement until they stopped the interferon alpha 2B therapy. The study, conducted by Tosti et al., found no correlation between the dosage of interferon alpha 2B and the timing or severity of the hair loss.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 131 results

    Similar Research

    5 / 1000+ results
      Current Management Strategies for Cutaneous T-Cell Lymphoma

      research Current Management Strategies for Cutaneous T-Cell Lymphoma

      39 citations, May 2004 in “Clinics in Dermatology”
      The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.
      Mucocutaneous Reactions to Chemotherapy

      research Mucocutaneous Reactions to Chemotherapy

      275 citations, March 1999 in “Journal of The American Academy of Dermatology”
      Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.
      Drug-Induced Hair Disorders

      research Drug-Induced Hair Disorders

      40 citations, August 2006 in “Current Drug Safety”
      Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.
      Interferons in Dermatology

      research Interferons in Dermatology

      22 citations, April 1998 in “Dermatologic Clinics”
      Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.